Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project
Open Access
- 13 September 2012
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 107 (8), 1418-1422
- https://doi.org/10.1038/bjc.2012.375
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Age-dependent accumulation of genomic aberrations and deregulation of cell cycle and telomerase genes in metastatic neuroblastomaInternational Journal of Cancer, 2012
- 2p24 Gain Region Harboring MYCN Gene Compared with MYCN Amplified and Nonamplified Neuroblastoma: Biological and Clinical CharacteristicsThe American Journal of Pathology, 2010
- High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onsetProceedings of the National Academy of Sciences of the United States of America, 2010
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology CommitteeBritish Journal of Cancer, 2009
- Overall Genomic Pattern Is a Predictor of Outcome in NeuroblastomaJournal of Clinical Oncology, 2009
- Significance of MYCN Amplification in International Neuroblastoma Staging System Stage 1 and 2 Neuroblastoma: A Report From the International Neuroblastoma Risk Group DatabaseJournal of Clinical Oncology, 2009
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force ReportJournal of Clinical Oncology, 2009
- Chromosome 1p and 11q Deletions and Outcome in NeuroblastomaThe New England Journal of Medicine, 2005
- Gain of Chromosome Arm 17q and Adverse Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1999
- Allelic Loss of Chromosome 1p as a Predictor of Unfavorable Outcome in Patients with NeuroblastomaThe New England Journal of Medicine, 1996